You just read:

Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease

News provided by

Ocugen, Inc.

20 Mar, 2018, 11:00 GMT